世界の早漏治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Premature Ejaculation Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4768
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、早漏治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（シアリス、バイアグラ、レビトラ）、用途別市場規模（スーパー、病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・早漏治療の市場動向
・企業の競争状況、市場シェア
・早漏治療の種類別市場規模（シアリス、バイアグラ、レビトラ）
・早漏治療の用途別市場規模（スーパー、病院、薬局、その他）
・早漏治療の北米市場規模2016-2027（アメリカ、カナダ）
・早漏治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・早漏治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・早漏治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・早漏治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Absorption Pharmaceuticals、Bayer、Eli Lilly、Regent Pacific Group、Dong-A Pharmaceutical、Emcure、Futura Medical、GlaxoSmithKline、NeuroHealing Pharmaceuticals）
・結論

Premature ejaculation is one of the most common sexual dysfunctions occurring in men.
A major reason for the market growth in the Americas is a significant rise in the number of premature ejaculation patients due to psychological factors such as strain and stress resulting from the ever-changing lifestyle.

Market Analysis and Insights: Global Premature Ejaculation Treatment Market
The global Premature Ejaculation Treatment market size is projected to reach US$ 2347 million by 2026, from US$ 1450.2 million in 2019, at a CAGR of 7.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Premature Ejaculation Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Premature Ejaculation Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Premature Ejaculation Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Premature Ejaculation Treatment market.

Global Premature Ejaculation Treatment Scope and Market Size
Premature Ejaculation Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Premature Ejaculation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cialis
Viagra
Levitra

Segment by Application
Supermarket
Hospital
Pharmacy
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Absorption Pharmaceuticals
Bayer
Eli Lilly
Regent Pacific Group
Dong-A Pharmaceutical
Emcure
Futura Medical
GlaxoSmithKline
NeuroHealing Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Premature Ejaculation Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cialis
1.2.3 Viagra
1.2.4 Levitra
1.3 Market by Application
1.3.1 Global Premature Ejaculation Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Supermarket
1.3.3 Hospital
1.3.4 Pharmacy
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Premature Ejaculation Treatment Market Perspective (2016-2027)
2.2 Premature Ejaculation Treatment Growth Trends by Regions
2.2.1 Premature Ejaculation Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Premature Ejaculation Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Premature Ejaculation Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Premature Ejaculation Treatment Industry Dynamic
2.3.1 Premature Ejaculation Treatment Market Trends
2.3.2 Premature Ejaculation Treatment Market Drivers
2.3.3 Premature Ejaculation Treatment Market Challenges
2.3.4 Premature Ejaculation Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Premature Ejaculation Treatment Players by Revenue
3.1.1 Global Top Premature Ejaculation Treatment Players by Revenue (2016-2021)
3.1.2 Global Premature Ejaculation Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Premature Ejaculation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Premature Ejaculation Treatment Revenue
3.4 Global Premature Ejaculation Treatment Market Concentration Ratio
3.4.1 Global Premature Ejaculation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Premature Ejaculation Treatment Revenue in 2020
3.5 Premature Ejaculation Treatment Key Players Head office and Area Served
3.6 Key Players Premature Ejaculation Treatment Product Solution and Service
3.7 Date of Enter into Premature Ejaculation Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Premature Ejaculation Treatment Breakdown Data by Type
4.1 Global Premature Ejaculation Treatment Historic Market Size by Type (2016-2021)
4.2 Global Premature Ejaculation Treatment Forecasted Market Size by Type (2022-2027)

5 Premature Ejaculation Treatment Breakdown Data by Application
5.1 Global Premature Ejaculation Treatment Historic Market Size by Application (2016-2021)
5.2 Global Premature Ejaculation Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Premature Ejaculation Treatment Market Size (2016-2027)
6.2 North America Premature Ejaculation Treatment Market Size by Type
6.2.1 North America Premature Ejaculation Treatment Market Size by Type (2016-2021)
6.2.2 North America Premature Ejaculation Treatment Market Size by Type (2022-2027)
6.2.3 North America Premature Ejaculation Treatment Market Size by Type (2016-2027)
6.3 North America Premature Ejaculation Treatment Market Size by Application
6.3.1 North America Premature Ejaculation Treatment Market Size by Application (2016-2021)
6.3.2 North America Premature Ejaculation Treatment Market Size by Application (2022-2027)
6.3.3 North America Premature Ejaculation Treatment Market Size by Application (2016-2027)
6.4 North America Premature Ejaculation Treatment Market Size by Country
6.4.1 North America Premature Ejaculation Treatment Market Size by Country (2016-2021)
6.4.2 North America Premature Ejaculation Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Premature Ejaculation Treatment Market Size (2016-2027)
7.2 Europe Premature Ejaculation Treatment Market Size by Type
7.2.1 Europe Premature Ejaculation Treatment Market Size by Type (2016-2021)
7.2.2 Europe Premature Ejaculation Treatment Market Size by Type (2022-2027)
7.2.3 Europe Premature Ejaculation Treatment Market Size by Type (2016-2027)
7.3 Europe Premature Ejaculation Treatment Market Size by Application
7.3.1 Europe Premature Ejaculation Treatment Market Size by Application (2016-2021)
7.3.2 Europe Premature Ejaculation Treatment Market Size by Application (2022-2027)
7.3.3 Europe Premature Ejaculation Treatment Market Size by Application (2016-2027)
7.4 Europe Premature Ejaculation Treatment Market Size by Country
7.4.1 Europe Premature Ejaculation Treatment Market Size by Country (2016-2021)
7.4.2 Europe Premature Ejaculation Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Premature Ejaculation Treatment Market Size (2016-2027)
8.2 Asia-Pacific Premature Ejaculation Treatment Market Size by Type
8.2.1 Asia-Pacific Premature Ejaculation Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Premature Ejaculation Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Premature Ejaculation Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Premature Ejaculation Treatment Market Size by Application
8.3.1 Asia-Pacific Premature Ejaculation Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Premature Ejaculation Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Premature Ejaculation Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Premature Ejaculation Treatment Market Size by Region
8.4.1 Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Premature Ejaculation Treatment Market Size (2016-2027)
9.2 Latin America Premature Ejaculation Treatment Market Size by Type
9.2.1 Latin America Premature Ejaculation Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Premature Ejaculation Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Premature Ejaculation Treatment Market Size by Type (2016-2027)
9.3 Latin America Premature Ejaculation Treatment Market Size by Application
9.3.1 Latin America Premature Ejaculation Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Premature Ejaculation Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Premature Ejaculation Treatment Market Size by Application (2016-2027)
9.4 Latin America Premature Ejaculation Treatment Market Size by Country
9.4.1 Latin America Premature Ejaculation Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Premature Ejaculation Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Premature Ejaculation Treatment Market Size (2016-2027)
10.2 Middle East & Africa Premature Ejaculation Treatment Market Size by Type
10.2.1 Middle East & Africa Premature Ejaculation Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Premature Ejaculation Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Premature Ejaculation Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Premature Ejaculation Treatment Market Size by Application
10.3.1 Middle East & Africa Premature Ejaculation Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Premature Ejaculation Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Premature Ejaculation Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Premature Ejaculation Treatment Market Size by Country
10.4.1 Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Absorption Pharmaceuticals
11.1.1 Absorption Pharmaceuticals Company Details
11.1.2 Absorption Pharmaceuticals Business Overview
11.1.3 Absorption Pharmaceuticals Premature Ejaculation Treatment Introduction
11.1.4 Absorption Pharmaceuticals Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.1.5 Absorption Pharmaceuticals Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Premature Ejaculation Treatment Introduction
11.2.4 Bayer Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Premature Ejaculation Treatment Introduction
11.3.4 Eli Lilly Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Regent Pacific Group
11.4.1 Regent Pacific Group Company Details
11.4.2 Regent Pacific Group Business Overview
11.4.3 Regent Pacific Group Premature Ejaculation Treatment Introduction
11.4.4 Regent Pacific Group Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.4.5 Regent Pacific Group Recent Development
11.5 Dong-A Pharmaceutical
11.5.1 Dong-A Pharmaceutical Company Details
11.5.2 Dong-A Pharmaceutical Business Overview
11.5.3 Dong-A Pharmaceutical Premature Ejaculation Treatment Introduction
11.5.4 Dong-A Pharmaceutical Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.5.5 Dong-A Pharmaceutical Recent Development
11.6 Emcure
11.6.1 Emcure Company Details
11.6.2 Emcure Business Overview
11.6.3 Emcure Premature Ejaculation Treatment Introduction
11.6.4 Emcure Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.6.5 Emcure Recent Development
11.7 Futura Medical
11.7.1 Futura Medical Company Details
11.7.2 Futura Medical Business Overview
11.7.3 Futura Medical Premature Ejaculation Treatment Introduction
11.7.4 Futura Medical Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.7.5 Futura Medical Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Premature Ejaculation Treatment Introduction
11.8.4 GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development
11.9 NeuroHealing Pharmaceuticals
11.9.1 NeuroHealing Pharmaceuticals Company Details
11.9.2 NeuroHealing Pharmaceuticals Business Overview
11.9.3 NeuroHealing Pharmaceuticals Premature Ejaculation Treatment Introduction
11.9.4 NeuroHealing Pharmaceuticals Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.9.5 NeuroHealing Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Premature Ejaculation Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cialis
Table 3. Key Players of Viagra
Table 4. Key Players of Levitra
Table 5. Global Premature Ejaculation Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Premature Ejaculation Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Premature Ejaculation Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Premature Ejaculation Treatment Market Share by Regions (2016-2021)
Table 9. Global Premature Ejaculation Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Premature Ejaculation Treatment Market Share by Regions (2022-2027)
Table 11. Premature Ejaculation Treatment Market Trends
Table 12. Premature Ejaculation Treatment Market Drivers
Table 13. Premature Ejaculation Treatment Market Challenges
Table 14. Premature Ejaculation Treatment Market Restraints
Table 15. Global Premature Ejaculation Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Premature Ejaculation Treatment Market Share by Players (2016-2021)
Table 17. Global Top Premature Ejaculation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premature Ejaculation Treatment as of 2020)
Table 18. Ranking of Global Top Premature Ejaculation Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Premature Ejaculation Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Premature Ejaculation Treatment Product Solution and Service
Table 22. Date of Enter into Premature Ejaculation Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Premature Ejaculation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Premature Ejaculation Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Premature Ejaculation Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Premature Ejaculation Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Premature Ejaculation Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Premature Ejaculation Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Premature Ejaculation Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Premature Ejaculation Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Premature Ejaculation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Premature Ejaculation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Premature Ejaculation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Premature Ejaculation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Premature Ejaculation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Premature Ejaculation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Premature Ejaculation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Premature Ejaculation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Premature Ejaculation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Premature Ejaculation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Premature Ejaculation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Premature Ejaculation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Premature Ejaculation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Premature Ejaculation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Premature Ejaculation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Premature Ejaculation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Premature Ejaculation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Premature Ejaculation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Premature Ejaculation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Premature Ejaculation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Premature Ejaculation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Premature Ejaculation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Premature Ejaculation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Premature Ejaculation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Premature Ejaculation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Premature Ejaculation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Absorption Pharmaceuticals Company Details
Table 63. Absorption Pharmaceuticals Business Overview
Table 64. Absorption Pharmaceuticals Premature Ejaculation Treatment Product
Table 65. Absorption Pharmaceuticals Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 66. Absorption Pharmaceuticals Recent Development
Table 67. Bayer Company Details
Table 68. Bayer Business Overview
Table 69. Bayer Premature Ejaculation Treatment Product
Table 70. Bayer Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 71. Bayer Recent Development
Table 72. Eli Lilly Company Details
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Premature Ejaculation Treatment Product
Table 75. Eli Lilly Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 76. Eli Lilly Recent Development
Table 77. Regent Pacific Group Company Details
Table 78. Regent Pacific Group Business Overview
Table 79. Regent Pacific Group Premature Ejaculation Treatment Product
Table 80. Regent Pacific Group Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 81. Regent Pacific Group Recent Development
Table 82. Dong-A Pharmaceutical Company Details
Table 83. Dong-A Pharmaceutical Business Overview
Table 84. Dong-A Pharmaceutical Premature Ejaculation Treatment Product
Table 85. Dong-A Pharmaceutical Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 86. Dong-A Pharmaceutical Recent Development
Table 87. Emcure Company Details
Table 88. Emcure Business Overview
Table 89. Emcure Premature Ejaculation Treatment Product
Table 90. Emcure Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 91. Emcure Recent Development
Table 92. Futura Medical Company Details
Table 93. Futura Medical Business Overview
Table 94. Futura Medical Premature Ejaculation Treatment Product
Table 95. Futura Medical Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 96. Futura Medical Recent Development
Table 97. GlaxoSmithKline Company Details
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 100. GlaxoSmithKline Recent Development
Table 101. NeuroHealing Pharmaceuticals Company Details
Table 102. NeuroHealing Pharmaceuticals Business Overview
Table 103. NeuroHealing Pharmaceuticals Premature Ejaculation Treatment Product
Table 104. NeuroHealing Pharmaceuticals Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 105. NeuroHealing Pharmaceuticals Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Premature Ejaculation Treatment Market Share by Type: 2020 VS 2027
Figure 2. Cialis Features
Figure 3. Viagra Features
Figure 4. Levitra Features
Figure 5. Global Premature Ejaculation Treatment Market Share by Application: 2020 VS 2027
Figure 6. Supermarket Case Studies
Figure 7. Hospital Case Studies
Figure 8. Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Premature Ejaculation Treatment Report Years Considered
Figure 11. Global Premature Ejaculation Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Premature Ejaculation Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Premature Ejaculation Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Premature Ejaculation Treatment Market Share by Regions (2022-2027)
Figure 15. Global Premature Ejaculation Treatment Market Share by Players in 2020
Figure 16. Global Top Premature Ejaculation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premature Ejaculation Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Premature Ejaculation Treatment Revenue in 2020
Figure 18. Global Premature Ejaculation Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Premature Ejaculation Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Premature Ejaculation Treatment Market Share by Type (2016-2027)
Figure 22. North America Premature Ejaculation Treatment Market Share by Application (2016-2027)
Figure 23. North America Premature Ejaculation Treatment Market Share by Country (2016-2027)
Figure 24. United States Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Premature Ejaculation Treatment Market Share by Type (2016-2027)
Figure 28. Europe Premature Ejaculation Treatment Market Share by Application (2016-2027)
Figure 29. Europe Premature Ejaculation Treatment Market Share by Country (2016-2027)
Figure 30. Germany Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Premature Ejaculation Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Premature Ejaculation Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Premature Ejaculation Treatment Market Share by Region (2016-2027)
Figure 40. China Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Premature Ejaculation Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Premature Ejaculation Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Premature Ejaculation Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Premature Ejaculation Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Premature Ejaculation Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Premature Ejaculation Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Absorption Pharmaceuticals Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 62. Regent Pacific Group Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 63. Dong-A Pharmaceutical Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 64. Emcure Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 65. Futura Medical Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 66. GlaxoSmithKline Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 67. NeuroHealing Pharmaceuticals Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の早産治療市場規模・現状・予測（2021年-2027年）

Global Premature Labor Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4769 2021年4月 93Pages
QYResearch社発行の本調査資料では、早産治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロゲステロン、OBE-022、レトシバン、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の前期破水（PROM）検査市場規模・現状・予測（2021年-2027年）

Global Premature Rupture of Membranes (PROM) Testing Market Size, Status and Forecast 2021-2027
QYR2104Z4770 2021年4月 90Pages
QYResearch社発行の本調査資料では、前期破水（PROM）検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ニトラジン/pH検査、シダ状結晶形成検査、アニシュア検査、その他）、用途別市場規模（病院、診療所、診断研究所、その他）、主要地域...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界のMSD治療市場規模・現状・予測（2021年-2027年）

Global MSD Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3939 2021年4月 91Pages
QYResearch社発行の本調査資料では、MSD治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジ...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の高カルシウム血症治療市場規模・現状・予測（2021年-2027年）

Global Hypercalcemia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2989 2021年4月 93Pages
QYResearch社発行の本調査資料では、高カルシウム血症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビスフォスフォネート、糖質コルチコイド、カルシウム模倣薬）、用途別市場規模（軽度高カルシウム血症、中度高カルシウム血症、重度高カルシ...

世界の神経芽細胞腫治療市場規模・現状・予測（2021年-2027年）

Global Neuroblastoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4085 2021年4月 90Pages
QYResearch社発行の本調査資料では、神経芽細胞腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（併用化学療法、モノクローナル抗体療法、ワクチン療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ...

世界の早産治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Premature Labor Treatment Market The global Premature Labor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
世界の前期破水（PROM）検査市場規模・現状・予測（2021年-2027年） The premature rupture of membranes (PROM) is a condition that occurs in pregnancy. It is defined as the breakage of the amniotic sac, which generally takes place one or two hours before the onset of contractions or labor. The early breakage of the membrane, i.e. before 37 weeks of gestation, can lea…
世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年） Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias. Market Analysis and Insights: Global Swedish Porphyria Treatment Market The global Swedish P…
世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年） ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer. Market Analysis and Insights: Global Acquired hemophilia A Treatment Market The global Acquired hemophilia A Treatment market size is projected to reach US$ X…
世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年） Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyr…